Literature DB >> 1681215

Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay.

L Bobo1, B Munoz, R Viscidi, T Quinn, H Mkocha, S West.   

Abstract

Detection of Chlamydia trachomatis eye infection is largely unsatisfactory by standard laboratory methods. A polymerase chain reaction/enzyme immunoassay (PCR-EIA) that had previously been successful for diagnosis of genital C trachomatis infection was compared with direct antibody immunofluorescence (DFA) for detection of the organism in conjunctival scrapes. 234 Tanzanian children aged 1-7 years living in a village that had had no previous trachoma control programme were classified clinically as having no sign of trachoma (0) n = 97, follicular trachoma (TF) n = 100, or intense inflammatory trachoma with or without TF (TI +/- TF) n = 37. PCR-EIA detected C trachomatis in 24%, 54%, and 95% of subjects, respectively, compared with elementary body (EB) detection by DFA of 1%, 28%, and 60%, respectively. Overall prevalence of chlamydial eye infection was 22% by DFA compared with 48% by PCR-EIA. Of subjects with chlamydial DNA at pretreatment, 103 (92%) had no detectable chlamydial DNA at the end of 4 weeks of ocular tetracycline. The findings show that PCR-EIA is likely to affect trachoma diagnosis and epidemiology because of the increased sensitivity for detection of C trachomatis in all clinical groups; the less stringent requirements for specimen collection and transport make this method suitable for field use. Moreover, the semi-quantitative aspect of PCR-EIA may be useful for monitoring a decrease in chlamydial DNA after treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681215     DOI: 10.1016/0140-6736(91)91502-l

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

Review 1.  Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey; A B Tullo
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Trachoma.

Authors:  D Mabey; N Fraser-Hurt
Journal:  BMJ       Date:  2001-07-28

3.  HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance.

Authors:  A G White; J Bogh; W Leheny; P Kuchipudi; M Varghese; H al Riyami; S al Hashmi; A S Daar
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

4.  Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men.

Authors:  J B Mahony; K E Luinstra; J W Sellors; D Jang; M A Chernesky
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid.

Authors:  Richard Rothman; Padmini Ramachandran; Samuel Yang; Andrew Hardick; Helen Won; Aleksandar Kecojevic; Celeste Quianzon; Yu-Hsiang Hsieh; Charlotte Gaydos
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

6.  Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.

Authors:  Jon L Yang; Julius Schachter; Jeanne Moncada; Dereje Habte; Mulat Zerihun; Jenafir I House; Zhaoxia Zhou; Kevin C Hong; Kathryn Maxey; Bruce D Gaynor; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

Review 7.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids.

Authors:  J B Mahony; K E Luinstra; J W Sellors; M A Chernesky
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers.

Authors:  Muneer Abbas; Linda D Bobo; Yu-Hsiang Hsieh; Noureddine Berka; Georgia Dunston; George E Bonney; Victor Apprey; Thomas C Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

10.  Trachoma rapid assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan.

Authors:  Emily Robinson; Lucia W Kur; Aggrey Ndyaba; Mounir Lado; Juma Shafi; Emmanuel Kabare; R Scott McClelland; Jan H Kolaczinski
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.